Akari Therapeutics Plc - American Depositary Shares (AKTX) earnings
Quarterly and annual AKTX reports and results, each read against the price at its own news timestamp. Back to the AKTX overview →
5 measured AKTX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform | Press release | +0.00% | +7.56% | |
| Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | — | +1.54% | |
| Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights | Press release | — | +1.41% | |
| Form 10-Q Akari Therapeutics Plc For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.78% | |
| Form 10-K Akari Therapeutics Plc For: Dec 31 | SEC filing · Form 10-K | +0.00% | -18.38% |
Keep exploring
More AKTX: analyst actions → · SEC filings → · AKTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BioLineRx Ltd. - American Depositary Shares (BLRX) | 148 | -0.82% | 40% |
| INMED PHARMACEUTICALS (IMLFF) | 148 | 0.00% | 48% |
| BeyondSpring, Inc. - Ordinary Shares (BYSI) | 146 | 0.00% | 49% |
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.